Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan...

Area of Science:

• Infectious Diseases
• Public Health
• Biomedical Research

Background:

• Severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) emerged 20 years ago, followed by other epidemics.
• The emergence of SARS-CoV-2 highlights the need for rapid countermeasure development during health crises.
• The National Institute of Allergy and Infectious Diseases (NIAID) published a pandemic preparedness plan in December 2021.

Purpose of the Study:

• To accelerate the discovery, development, and evaluation of medical countermeasures.
• To prepare for future pandemics by focusing on priority pathogens, technology platforms, and prototype pathogens.
• To present a research strategy utilizing a prototype pathogen approach for public health protection.

Main Methods:

• The study outlines a research strategy focused on select prototype pathogens.
• Leveraging established strategies from the SARS-CoV-2 response.
• Building upon the NIAID's pandemic preparedness plan.

Main Results:

• The prototype pathogen approach is presented as a cornerstone for biomedical research preparedness.
• This strategy aims to protect public health from new and reemerging infectious diseases.
• The approach facilitates rapid countermeasure development.

Conclusions:

• A prototype pathogen strategy is crucial for effective pandemic preparedness.
• This approach enhances the ability to respond to emerging infectious disease threats.
• Biomedical research preparedness is essential for safeguarding public health.